STOCK TITAN

CLEVER LEAVES HLDGS (CLVR) Financials

CLVR OTC
FY2023 annual
Revenue $17.4M +6.1% YoY
Net Income -$17.9M n/m YoY
EPS (Diluted) -$11.42 n/m YoY
Free Cash Flow -$11.5M n/m YoY
Source SEC Filings (10-K/10-Q) Latest period FY2023, ended Dec 31, 2023 Reported Currency USD FYE December

Newest figures come from the 10-K for FY2023, filed Apr 1, 2024. Each column of the statement tables below links to the filing it was taken from.

CLEVER LEAVES HLDGS INC (CLVR) reported $17.4M in revenue for fiscal year 2023, up 6.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CLVR FY2023

Revenue is growing modestly, but thinner margins and continued cash losses leave the business not yet self-funding.

FY2023 revenue rose 6.1% while gross profit fell 9.2%, showing that added sales did not translate into stronger product economics. The net loss narrowed to $17.9M, while operating cash flow remained negative at -$11.5M; accounting improvement therefore coincided with less cash leaving the business, but not with positive cash generation.

The operating loss improved by 196.4 percentage points to a still-negative -89.5% margin as SG&A fell 22.1% and R&D fell 33.7%. Because cost reductions outpaced revenue growth while gross margin fell to 37.6%, the improvement appears driven more by overhead contraction than by healthier underlying gross economics.

FY2023 capital expenditures were only $31K against operating cash flow of -$11.5M, leaving free cash flow at -$11.5M; the shortfall was therefore overwhelmingly operational rather than expansion-related. Debt-to-equity was just 0.1x and liabilities represented 22.5% of assets, so the reported strain is centered more on self-funding operations than on heavy leverage.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

CLEVER LEAVES HLDGS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress
-9.68

CLEVER LEAVES HLDGS INC scores -9.68, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $198.8M against total assets of $31.2M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
3/9

CLEVER LEAVES HLDGS INC passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.

Earnings Quality No Cash Backing
N/A

CLEVER LEAVES HLDGS INC reported a net loss of $17.9M while operations used $11.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

CLEVER LEAVES HLDGS INC reported an operating loss of $15.6M against $46K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$4.6M
YoY+5.4%
QoQ+21.4%

CLEVER LEAVES HLDGS INC generated $4.6M in revenue in Q4 2023. This represents an increase of 5.4% from the same quarter a year earlier. Against the prior quarter it is up 21.4%.

EBITDA
-$4.7M
YoYn/m
QoQn/m

CLEVER LEAVES HLDGS INC's EBITDA was -$4.7M in Q4 2023, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$5.1M
YoYn/m
QoQn/m

CLEVER LEAVES HLDGS INC reported a net loss of $5.1M in Q4 2023. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$2.95
QoQn/m

CLEVER LEAVES HLDGS INC earned -$2.95 per diluted share (EPS) in Q4 2023. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Cash & Debt
$6.8M
YoY-45.1%
QoQ+5.5%

CLEVER LEAVES HLDGS INC held $6.8M in cash against $1.2M in long-term debt as of Q4 2023.

Shares Outstanding
2M
QoQ+0.6%

CLEVER LEAVES HLDGS INC had 2M shares outstanding in Q4 2023. Against the prior quarter it is up 0.6%.

Free Cash Flow

Not reported for Q4 2023.

Dividends Per Share

Not reported for Q4 2023.

Margins & Returns

Gross Margin
-7.5%
YoY-26.6pp
QoQ-58.3pp

CLEVER LEAVES HLDGS INC's gross margin was -7.5% in Q4 2023, indicating the percentage of revenue retained after direct costs. This is down 26.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 58.3 percentage points.

Return on Equity
-21.0%
YoY+50.3pp
QoQ-3.7pp

CLEVER LEAVES HLDGS INC's quarterly ROE was -21.0% in Q4 2023: one quarter's net income over shareholder equity, not annualized. This is up 50.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.7 percentage points.

Operating Margin

Not shown for Q4 2023: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q4 2023: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$233K
YoY-61.5%
QoQ-20.2%

CLEVER LEAVES HLDGS INC invested $233K in research and development in Q4 2023. This represents a decrease of 61.5% from the same quarter a year earlier. Against the prior quarter it is down 20.2%.

Share Buybacks

Not reported for Q4 2023.

Capital Expenditures

Not reported for Q4 2023.

CLVR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CLVR quarterly income statement
MetricQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-Q
Revenue$4.6M+5.4%$3.8M+33.2%$5.0M+21.5%$4.0M-21.1%$4.4M+5.0%$2.9M-28.9%$4.1M+11.7%$5.0M+45.0%
Cost of Revenue$5.0M+40.1%$1.9M+19.8%$2.3M+39.3%$1.7M-28.8%$3.6M+10.4%$1.6M-25.3%$1.6M-15.0%$2.4M+83.1%
Gross Profit-$346K-141.0%$1.9M+49.5%$2.7M+9.9%$2.2M-13.8%$844K-13.0%$1.3M-32.7%$2.5M+40.3%$2.6M+21.2%
R&D Expenses$233K-61.5%$292K-14.9%$403K+12.3%$212K-48.5%$605K+18.9%$343K-24.4%$359K+17.7%$412K+48.2%
SG&A Expenses$4.1M-14.3%$4.7M-21.8%$5.3M-26.3%$5.9M-23.5%$4.8M-59.3%$6.1M-44.0%$7.2M-32.2%$7.7M-14.6%
Operating Income-$4.9Mn/m-$3.4Mn/m-$3.2Mn/m-$4.1Mn/m-$7.5Mn/m-$24.3Mn/m-$5.3Mn/m-$9.7Mn/m
EBITDA-$4.7Mn/m-$3.1Mn/m-$3.0Mn/m-$3.9Mn/m-$7.2Mn/m-$24.0Mn/m-$5.0Mn/m-$9.4Mn/m
Interest Expense-$11K$5K$35K-94.6%$17KN/AN/A$645KN/A
Net Income-$5.1Mn/m-$5.1Mn/m-$3.6Mn/m-$4.1Mn/m-$28.8Mn/m-$20.2M-2126.4%-$1.0Mn/m-$16.1Mn/m
EPS (Basic)-$2.95-$3.25-$0.08n/m-$0.09-$0.70-$14.33-$0.03n/m-$0.58n/m
EPS (Diluted)-$2.95-$3.25-$0.08n/m-$0.09-$0.70-$14.33-$0.03n/m-$0.58n/m
Diluted Shares (Avg)N/A2M45M+13.4%44MN/A1M40M+54.6%28M+11.7%

Not reported in any period shown, so not listed: Income Tax.

CLVR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CLVR quarterly balance sheet
MetricQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-Q
Total Assets$31.2M-40.0%$37.8M-53.6%$42.8M-59.4%$46.2M-63.7%$52.1M-55.1%$81.4M-42.3%$105.5M-29.6%$127.2M-19.8%
Current Assets$13.9M-46.9%$17.9M-55.8%$18.4M-58.4%$21.1M-69.4%$26.2M-56.5%$40.5M-40.4%$44.3M-42.9%$69.2M-20.8%
Cash & Equivalents$6.8M-45.1%$6.5M-62.3%$5.1M-73.3%$6.4M-85.6%$12.4M-66.6%$17.2M-62.5%$19.0M-66.4%$44.3M-35.5%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Inventory$4.5M-46.6%$7.7M-53.7%$7.5M-55.4%$8.0M-50.6%$8.4M-45.5%$16.7M+18.4%$16.7M+27.3%$16.2M+40.5%
Accounts Receivable$907K-59.7%$1.7M-32.6%$2.6M-23.6%$2.6M+2.6%$2.3M+1.4%$2.6M+20.0%$3.4M+109.3%$2.6M+48.6%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
GoodwillN/AN/AN/AN/A$0n/mN/AN/AN/A
Total Liabilities$7.0M-39.9%$8.1M-32.1%$8.9M-57.4%$9.5M-78.9%$11.7M-73.1%$11.9M-77.7%$20.9M-70.6%$44.8M-39.7%
Current Liabilities$5.8M-38.4%$6.8M-16.7%$7.6M-12.5%$7.8M-71.6%$9.4M-65.4%$8.2M-74.8%$8.6M-84.7%$27.5M-11.3%
Non-Current Liabilities$1.2M-46.3%$1.2M-66.4%$1.3M-89.2%$1.7M-90.4%$2.3M-86.0%$3.7M-82.2%$12.2M-14.8%$17.3M-60.0%
Long-Term Debt$1.2M+14.4%$1.3M-3.4%$1.4M-14.3%$1.5M-76.0%$1.1M-86.0%$1.4M-76.4%$1.6M-75.5%$6.1M-82.5%
Total Equity$24.2M-40.1%$29.7M-57.3%$33.9M-59.9%$36.8M-55.4%$40.4M-44.5%$69.5M-20.7%$84.6M+7.3%$82.4M-2.4%
Retained Earnings-$198.8Mn/m-$193.7Mn/m-$188.6Mn/m-$185.0Mn/m-$180.9Mn/m-$152.1Mn/m-$131.9Mn/m-$130.9Mn/m

CLVR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CLVR quarterly cash flow statement
MetricQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-Q
Operating Cash Flow-$1.5Mn/m-$2.2Mn/m-$1.7Mn/m-$6.1Mn/m-$5.1Mn/m-$5.4Mn/m-$8.2Mn/m-$10.4Mn/m
Depreciation & Amortization$231K-20.6%$290K-4.9%$224K-29.6%$236K-27.8%$291K-11.3%$305K-9.5%$318K-39.3%$327K-43.5%
Stock-Based CompensationN/A$52K-94.6%$434K-62.2%$468K-6.4%N/A$958K-70.6%$1.1M-65.5%$500K-67.7%
Capital ExpendituresN/A$108K-57.6%$44K-88.6%$35K-97.1%N/A$255K-84.3%$386K-81.6%$1.2M-45.2%
Free Cash FlowN/A-$2.3Mn/m-$1.7Mn/m-$6.1Mn/mN/A-$5.6Mn/m-$8.6Mn/m-$11.6Mn/m
Investing Cash Flow$2.1M+273.8%$2.7Mn/m-$44K-102.1%-$35Kn/m$550Kn/m-$255Kn/m$2.1Mn/m-$1.2Mn/m
Financing Cash Flow-$162Kn/m$760K-80.4%$165Kn/m-$107K-100.6%-$250K-128.3%$3.9Mn/m-$19.0Mn/m$18.7M+609.9%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CLVR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CLVR quarterly financial ratios
MetricQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-Q
Gross Margin-7.5%-26.6pp50.8%+5.5pp54.7%-5.8pp56.2%+4.7pp19.2%-4.0pp45.3%-2.6pp60.5%+12.4pp51.4%-10.1pp
Operating Margin-105.9%-88.4%-63.7%-103.8%-171.0%-848.4%-130.4%-192.8%
Net Margin-109.6%-134.5%-72.2%-46.7pp-102.6%-654.6%-703.3%-25.5%-320.2%
Return on Equity-21.0%+50.3pp-17.3%+11.7pp-10.6%-9.3pp-11.1%+8.5pp-71.3%-38.3pp-29.0%-30.1pp-1.2%+10.1pp-19.6%-3.3pp
Return on Assets-16.3%+39.0pp-13.6%+11.2pp-8.4%-7.4pp-8.8%+3.9pp-55.3%-34.7pp-24.8%-25.5pp-1.0%+5.0pp-12.7%-4.0pp
Current Ratio2.40-0.4x2.62-2.3x2.43-2.7x2.71+0.2x2.78+0.6x4.93+2.8x5.12+3.8x2.52-0.3x
Debt-to-Equity0.050.0x0.040.0x0.040.0x0.040.0x0.03-0.1x0.020.0x0.02-0.1x0.07-0.3x
Liabilities-to-Equity0.290.0x0.27+0.1x0.260.0x0.26-0.3x0.29-0.3x0.17-0.4x0.25-0.7x0.54-0.3x
Asset Turnover0.15+0.1x0.10+0.1x0.12+0.1x0.090.0x0.080.0x0.040.0x0.040.0x0.040.0x
FCF MarginN/A-60.5%-34.8%-153.7%N/A-196.7%-209.7%-229.8%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
CLEVER LEAVES HLDGS INC CLVR FY2023 $17.4M -$17.9M N/A $20K —
CANNAPHARMARX INC CPMD FY2025 $1.4M -$11.1M N/A $1.4M —

Frequently Asked Questions

What is CLEVER LEAVES HLDGS INC's annual revenue?

CLEVER LEAVES HLDGS INC (CLVR) reported $17.4M in total revenue for fiscal year 2023. This represents a 6.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CLEVER LEAVES HLDGS INC's revenue growing?

CLEVER LEAVES HLDGS INC (CLVR) revenue grew by 6.1% year-over-year, from $16.4M to $17.4M in fiscal year 2023.

Is CLEVER LEAVES HLDGS INC profitable?

No, CLEVER LEAVES HLDGS INC (CLVR) reported a net loss of $17.9M in fiscal year 2023.

CLEVER LEAVES HLDGS INC (CLVR) reported diluted earnings per share of -$11.42 for fiscal year 2023. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CLEVER LEAVES HLDGS INC (CLVR) had EBITDA of -$14.6M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2023, CLEVER LEAVES HLDGS INC (CLVR) had $6.8M in cash and equivalents against $1.2M in long-term debt.

CLEVER LEAVES HLDGS INC (CLVR) had a gross margin of 37.6% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.

CLEVER LEAVES HLDGS INC (CLVR) had an operating margin of -89.5% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.

CLEVER LEAVES HLDGS INC (CLVR) has a return on equity of -73.9% for fiscal year 2023, measuring how efficiently the company generates profit from shareholder equity.

CLEVER LEAVES HLDGS INC (CLVR) recorded an outflow of $11.5M in free cash flow during fiscal year 2023. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

CLEVER LEAVES HLDGS INC (CLVR) recorded an outflow of $11.5M in operating cash flow during fiscal year 2023, representing cash used by core business activities.

CLEVER LEAVES HLDGS INC (CLVR) had $31.2M in total assets as of fiscal year 2023, including both current and long-term assets.

CLEVER LEAVES HLDGS INC (CLVR) invested $31K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.

CLEVER LEAVES HLDGS INC (CLVR) invested $1.1M in research and development during fiscal year 2023.

CLEVER LEAVES HLDGS INC (CLVR) had 2M shares outstanding as of fiscal year 2023.

CLEVER LEAVES HLDGS INC (CLVR) had a current ratio of 2.40 as of fiscal year 2023, which is generally considered healthy.

CLEVER LEAVES HLDGS INC (CLVR) had a debt-to-equity ratio of 0.05 as of fiscal year 2023. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

CLEVER LEAVES HLDGS INC (CLVR) had a liabilities-to-equity ratio of 0.29 as of fiscal year 2023, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

CLEVER LEAVES HLDGS INC (CLVR) had a return on assets of -57.3% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2023, CLEVER LEAVES HLDGS INC (CLVR) held $6.8M in cash, cash equivalents and investments, and reported an operating cash outflow of $11.5M over that year. Dividing the one by the other, the reported balance equals about 7 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

CLEVER LEAVES HLDGS INC (CLVR) has an Altman Z-Score of -9.68, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

CLEVER LEAVES HLDGS INC (CLVR) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

CLEVER LEAVES HLDGS INC (CLVR) reported a net loss of $17.9M while operations used $11.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

CLEVER LEAVES HLDGS INC (CLVR) reported an operating loss of $15.6M against $46K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top